爱美客：子公司米诺地尔搽剂获得药品注册证书

Core Viewpoint - The company announced that its wholly-owned subsidiary, Beijing Nobot Biotechnology Co., Ltd., has received approval from the National Medical Products Administration for the Minoxidil topical solution registration certificate, indicating a significant development in its product offerings in the dermatology sector [1] Group 1 - The Minoxidil topical solution is classified as a non-prescription dermatological medication [1] - The 2% formulation is intended for the treatment of male pattern hair loss and alopecia areata [1] - The 5% formulation is restricted for male use only, specifically for treating male pattern hair loss and alopecia areata [1]